Venus Concept VERO
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Venus Concept (VERO) Business Model and Operations Summary
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Key Insights
Venus Concept (VERO) Core Market Data and Business Metrics
Latest Closing Price
$2.62Market Cap
$1.80 MillionAverage Daily Trade Volume
63,053 SharesPrice-Earnings Ratio
-0.03Total Outstanding Shares
660,000 SharesCEO
Mr. Rajiv Kanishka Liyanaarchchie De SilvaTotal Employees
304Dividend
No dividendIPO Date
October 12, 2017SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
235 Yorkland Blvd., Toronto, A6, M2J 4Y8
Historical Stock Splits
If you bought 165 shares of VERO before May 12, 2023, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| March 4, 2025 | 1-for-11 (Reverse Split) |
| May 12, 2023 | 1-for-15 (Reverse Split) |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $-8.03 Million |
| Net Cash Flow, Continuing | $-437,000 |
| Net Cash Flow From Operating Activities | $-8.03 Million |
| Net Cash Flow From Financing Activities | $7.67 Million |
| Net Cash Flow | $-437,000 |
| Net Cash Flow From Investing Activities, Continuing | $-70,000 |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Diluted Earnings Per Share | $-8.02 |
| Net Income/Loss Available To Common Stockholders, Basic | $-50.15 Million |
| Gross Profit | $45.48 Million |
| Net Income/Loss | $-50.10 Million |
| Revenues | $67.20 Million |
| Income/Loss From Continuing Operations After Tax | $-50.10 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-50.10 Million |
| Comprehensive Income/Loss | $-50.10 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $520,000 |
| Accounts Receivable | $21.10 Million |
| Liabilities And Equity | $72.28 Million |
| Current Assets | $51.22 Million |
| Equity | $10.63 Million |
| Equity Attributable To Parent | $10.11 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||